Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis

Clinical trial NCT05945615 · COMPLETED

Trial details

NCT number: NCT05945615
Sponsor: Milton S. Hershey Medical Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Blepharoptosis Synkinesis Hyperkinesis Facial Paralysis

Start date: 2024-01-11
Primary completion: 2026-01-08
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.